Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Research results from University of Amsterdam update understanding of adenocarcinoma
May 20th, 2008
"Oesophageal adenocarcinoma is an aggressive malignancy with propensity for early lymphatic and haematogenous dissemination. Since conventional TNM staging does not provide accurate prognostic information, novel molecular prognostic markers and potential therapeutic targets are subject of intense research," investigators in Netherlands report. "The aim of the present study was to study the prognostic significance of Met, the hepatic growth factor ( HGF) receptor and a possible target for therapy in comparison to cyclooxygenase- 2 ( COX- 2). Tumour sections from 145 consecutive patients undergoing intentionally curative surgery for oesophageal adenocarcinoma were...
Source: Cancer Weekly (2008-05-20)
|
